Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106397117A details a novel enzymatic resolution process yielding high-purity chiral alcohols with significant supply chain and cost advantages for global buyers.
Patent CN104450853B reveals green recycling method. Reduces waste and ensures high-purity pharmaceutical intermediates for cost-effective manufacturing and supply chain reliability.
Patent CN1993472A details a lipase-catalyzed route for chiral 3-hydroxy acids, offering cost reduction in API manufacturing and superior supply chain reliability.
Patent CN102887885A details a high-purity Esomeprazole Sodium synthesis via inclusion complex resolution, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1177958A details a lipase-catalyzed resolution of pyrazole carbinols. Discover cost-effective, high-purity manufacturing solutions for analgesic intermediates.
Patent CN114163411A details a scalable crystallization resolution method for dihydromyricetin offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced Friedel-Crafts route for dexmedetomidine HCl offers superior yield and purity. A cost-effective solution for pharmaceutical intermediates manufacturing and supply chain stability.
Optimized synthesis route for Tenofovir Alafenamide reduces costs and improves chirality. Reliable supply chain partner for high-purity pharmaceutical intermediates manufacturing.
Patent CN1742002A discloses novel piperazine intermediates for Levocetirizine. Discover high-purity synthesis routes offering significant cost reduction and supply reliability.
Patent CN100427460C details a scalable L-norvaline synthesis from n-valeric acid, offering cost reduction in API manufacturing and high-purity chiral intermediates.
Patent CN104193635A offers high-purity pregabalin synthesis via Hofmann degradation ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101973904B reveals organic acid salification for Lisinopril intermediate. Ensures high optical purity and scalable production for global supply chains.
Patent CN110845305B details a high-yield route to L-menthol using organoaluminum catalysts and chiral resolution, offering cost-effective supply chain solutions.
Patent CN106749177A details a novel tartaric acid purification method for SYR-322, ensuring high purity and cost reduction in API manufacturing for global supply chains.
Patent CN101974603B reveals a novel NAD-independent enzymatic resolution method for high-purity D-alpha-hydroxybutyric acid, offering significant cost reduction and scalable supply chain solutions.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN110066835B details a novel lipase resolution process for agrochemical intermediates, offering superior enantioselectivity and cost-effective manufacturing solutions.
Patent CN109182298A reveals high-efficiency CALB mutants for chiral intermediate synthesis, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.